Skip to main content
. 2024 Dec 19;19(1):e12058. doi: 10.1002/ccs3.12058

FIGURE 3.

FIGURE 3

ANXA114‐26 promotes apoptosis and reduces drug resistance in ovarian cancer cells by competitively binding to the FPR receptor with ANXA1. (A) The relative expression of BAX mRNA. (B) The relative expression of Bcl‐2 mRNA. (C) The relative expression of MRP1 mRNA. (D) Protein expression levels of BAX,Bcl‐2 and MRP1. (E) Changes in cell viability in SKOV3 cell lines. (F) Changes in cell viability in SKOV3/DDP cell lines. (G) The relative expression of BAX mRNA. (H) The relative expression of Bcl‐2 mRNA. (I) The relative expression of MRP1 mRNA. (J) Protein expression levels of BAX,Bcl‐2 and MRP1. The data are represented as the mean ± SD. The data were independently replicated in triplicate., *p < 0.05, **p < 0.01. Compared to ANXA114‐26 + Ac2‐26, # p < 0.05, ## p < 0.01.